011503 Dapsone 6% / Niacinamide 2% / Spironolactone 5%
Product Images NDC 72934-1211

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for 011503 Dapsone 6% / Niacinamide 2% / Spironolactone 5% (NDC 72934-1211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

W (2 End)

Sincerus Florida, LLC is a company based in Pompano Beach, FL that can be contacted at (800) 604-5032. This company may be contacted to report suspected adverse reactions, and information can also be obtained through the FDA's website or by contacting the FDA at (800) FDA-1088. The LS-01-00000-00 is for office use only and is not intended for resale.*

FDA Label Image

D (1211 2 Front)

FDA Label Image

S (1211 2 Middle)

This text appears to be a list of ingredients and their corresponding percentages in a product. The product contains Butylated Hydroxytoluene NF BHT at 0.1%, EAVERARHBIN at 0.25%, and PropyleneGlcolUSP at 5%. The purpose or type of product is not clear from this text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.